For citations:
Frolova MA, Glazkova EB, Stenina MB. Palbociclib in the first line combination hormone therapy of HER2- negative metastatic hormone-dependent breast cancer. Clinical follow-up. Meditsinskiy sovet = Medical Council. 2018;(10):158-160. (In Russ.) https://doi.org/10.21518/2079-701X-2018-10-158-160